Oxford University Press

SHERPA: Yellow

People

  1. De Angelis
    De Angelis
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Mellinghoff
    Mellinghoff
  5. Rosenblum
    Rosenblum
  6. Shuman
    Shuman
  7. Dunkel
    Dunkel
  8. Karajannis
    Karajannis
  9. Saltz
    Saltz
  10. Souweidane
    Souweidane

Groups

  1. Department of Medicine (1983)
  2. Solid Tumor Oncology Division (1615)
  3. GSK Faculty (761)
  4. Survivorship Research (635)
  5. Population Sciences Research Program (612)
  6. Epidemiology and Biostatistics (463)
  7. Department of Pathology and Laboratory Medicine (412)
  8. Gastrointestinal Oncology Service (385)
  9. Genitourinary Oncology Service (364)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2093)
  2. Meeting Abstract (2072)
  3. Book Section (179)
  4. Review (88)
  5. Editorial (80)
  6. Guidelines (35)
  7. Correspondence (24)
  8. Book Whole (17)
  9. Conference Paper (15)
  10. Research Letter (9)
Groups
  1. Department of Medicine (1983)
  2. Solid Tumor Oncology Division (1615)
  3. GSK Faculty (761)
  4. Survivorship Research (635)
  5. Population Sciences Research Program (612)
  6. Epidemiology and Biostatistics (463)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Marc Rosenblum (87)
  6. Stewart Shuman (87)

More People

Years
  1. 2025 (65)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1666)
  2. Neuro-Oncology (845)
  3. JNCI: Journal of the National Cancer Institute (482)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (105)

More Publications

Results (4612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cognitive function in long-term testicular cancer survivors: Impact of modifiable factors
    Journal Article

    Dinh, P. C. Jr; Monahan, P. O.; Fung, C.; Sesso, H. D.; Feldman, D. R.; Vaughn, D. J.; Hamilton, R. J.; Huddart, R.; Martin, N. E.; Kollmannsberger, C.; more...
    JNCI Cancer Spectrum (2024)

    Fulltext@MSK | Save
  • Report on Pediatric Brain Tumor Consortium (PBTC)-029b, a prospective phase 2 clinical trial of selumetinib in treating young patients with recurrent/progressive low-grade glioma: New results on strata 2, 5, and 6 with updated long-term survival outcomes on strata 1, 3, and 4
    Meeting Abstract

    Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Lensing, S.; Ligon, A. H.; Lindeman, N.; Banerjee, A.; Kilburn, L.; Lenzen, A.; Pillay-Smiley, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • CNS sarcomas withCIC- ORATXN1-alterations — A meta-analysis of clinical and molecular features in a large series of patients
    Meeting Abstract

    Geisemeyer, N.; Federico, A.; Sill, M.; Rosenblum, M.; Bale, T.; Mauermann, M.; Schrimpf, D.; Johann, P.; Pickles, J.; Aldape, K.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Subgroup and subtype-specific outcomes in metastatic infant medulloblastoma
    Meeting Abstract

    Senapati, A.; Lindsay, H.; Gilheeney, S.; Bale, T.; Taylor, M.; Khuong-Quang, D. A.; Bouffet, E.; Khan, S.; van Veelan, M. L.; Kros, J. M.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of entrectinib in children withNTRK orros1 fusion-positive (fp) primary central nervous system (CNS) tumors
    Meeting Abstract

    Bagchi, A.; Robinson, G. W.; Desai, A. V.; Wu, Y.; Wang, H.; Basu, E. M.; Casanova, M.; van Tilburg, C. M.; Campbell-Hewson, Q.; Armstrong, A. E.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and survival outcomes of diffuse hemispheric glioma, H3 G34-mutant: Interim results of a multicentre international study
    Meeting Abstract

    Crowell, C.; Bennett, J.; Bandopadhayay, P.; Sturm, D.; Green, A. L.; MacNeil, M.; Vanan, M. I.; Larouche, V.; Renzi, S.; Imber, B.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Pilot study to evaluate automated laboratory data transfer into Medidata Rave across the National Cancer Institute (NCI)-supported Pediatric Brain Tumor Consortium (PBTC) and Pediatric Early Phase Clinical Trial Network (PEP-CTN) cooperative groups
    Meeting Abstract

    Miler, T. P.; Aplenc, R.; Minard, C.; Lensing, S.; Wang, Y.; Velamuru, P.; Foster, J. H.; Silverman, M.; Sung, C.; Wong, K.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Medical and surgical variables associated with relapse in central nervous system (CNS) nongerminomatous germ cell tumors (NGGCTS): Secondary analysis of stratum 1 of the Children's Oncology Group ACNS1123 phase 2 clinical trial
    Meeting Abstract

    Nagabushan, S.; Yan, R.; Lin, T.; Onar-Thomas, A.; Souweidane, M. M.; Dhall, G.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST)
    Meeting Abstract

    de la Fuente, M.; Butowski, N. A.; Taylor, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Allen, C. E.; Ammakkanavar, N.; Michelson, G.; Jiang, P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1 Study of the Cd40 agonistic monoclonal antibody APX005M (sotigalimab) in pediatric, adolescent, and young adult patients with recurrent or progressive CNS tumors and newly diagnosed brain stem glioma: A Pediatric Brain Tumor Consortium study (PBTC-051; NCT03389802)
    Meeting Abstract

    Lindsay, H. B.; Billups, C.; Baxter, P.; Hwang, E.; Lenzen, A.; MacDonald, T.; Pollack, I. F.; Robison, N.; Vinitsky, A.; Poussaint, T. Y.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save